NCT03556709

Brief Summary

The purpose of this research study is to test the utility of an ankle robot, when used during treadmill walking, in people with ankle weakness and foot drop from a peripheral nervous system injury due to neuromuscular or orthopedic injury.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started Aug 2018

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Aug 2018Dec 2028

First Submitted

Initial submission to the registry

June 4, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
10.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

June 14, 2018

Status Verified

June 1, 2018

Enrollment Period

10.4 years

First QC Date

June 4, 2018

Last Update Submit

June 4, 2018

Conditions

Outcome Measures

Primary Outcomes (6)

  • Gait velocity during self-selected overground walking

    cm/sec

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

  • Peak dorsiflexion angle during swing phase of gait

    degrees; extent of ankle dorsiflexion to enable foot clearance

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

  • Ankle dorsiflexion-plantarflexion range of motion

    degrees

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

  • Postural sway areas during quiet standing

    cm\^2; extent of postural deviations to assess static postural control

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

  • Ratio of asymmetric loading in quiet standing

    ratio of Newtons of force per each leg (paretic/nonparetic) while standing quietly

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

  • Push-off forces during gait initiation

    Newtons; magnitude of forward ground reaction forces.

    Change from baseline to: post-6 weeks of training, and 6 weeks after completion of training

Study Arms (1)

Treadmill Ankle Robot Training

EXPERIMENTAL
Device: Treadmill Ankle Robot Training

Interventions

This intervention employs the use of an adaptive ankle robot control system, during treadmill walking, over a 6-week intervention period.

Treadmill Ankle Robot Training

Eligibility Criteria

Age18 Years - 88 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women, aged 18 to 88 years
  • Chronic foot drop and ankle weakness in one leg from a peripheral nervous system injury due to a neuromuscular or orthopedic injury
  • Ability to walk 10 meters and arise from a chair with no human assistance (but usage of usual assistive device\[s\] is permitted)

You may not qualify if:

  • Cardiac history of (a) unstable angina; (b) recent (less than 3 months) myocardial infarction, congestive heart failure (NYHA category II); and/or (c) hemodynamically significant valvular dysfunction
  • Hypertension that is a contraindication for a bout of walking training (greater than 160/100 mmHg on two assessments)
  • Medical history of (a) recent hospitalization (less than 3 months) for severe medical disease; (b) symptomatic peripheral arterial occlusive disease; (c) orthopedic or chronic pain conditions that significantly alter gait function; (d) pulmonary or renal failure; and/or (e) active cancer
  • Current participation in orthopedic or rehabilitation medical programs
  • Active deep venous thrombosis
  • Distal paretic leg skin lesions, infections, or soft tissue inflammation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Peroneal NeuropathiesPeripheral Nervous System DiseasesGait Disorders, NeurologicMobility Limitation

Condition Hierarchy (Ancestors)

MononeuropathiesNeuromuscular DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Charlene E. Hafer-Macko, M.D.

    Baltimore VA Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Neurology

Study Record Dates

First Submitted

June 4, 2018

First Posted

June 14, 2018

Study Start

August 1, 2018

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

June 14, 2018

Record last verified: 2018-06

Data Sharing

IPD Sharing
Will not share